This upcoming Sunday, the people of Venezuela will hold an election that, if legitimate, would put an end to years of the oppressive Maduro narco-regime. U.S. Senator Marco Rubio (R-FL) issued a statement in support of the Venezuelan people: “The...
Este próximo domingo, el pueblo venezolano tendrá una elección que, de ser legítima, pondría fin a años de opresión por parte del narco-régimen de Maduro. El senador estadounidense Marco Rubio (R-FL) grabó un mensaje de video en español y emitió una declaración en...
Twenty-three years ago, the United States was attacked by Islamic terrorists on September 11, 2001. Now, Zacarias Moussaoui, the only person convicted in a U.S. court for his role in the attack, has requested the U.S. Department of Justice to allow a prisoner transfer...
U.S. Senator Marco Rubio’s (R-FL) office will host virtual Mobile Office Hours next week to assist constituents with federal casework issues in their respective local communities. These office hours offer constituents who do not live close to one of Senator Rubio’s...
As the U.S. Department of Veterans Affairs (VA) opens up new facilities, many veterans are losing access to the VA’s Community Care Program and, consequently, their long-term healthcare providers. Veterans throughout the country have reported a loss of care, including...
The U.S.-India partnership is vital to countering influences from Communist China. In order to strengthen this partnership, it is essential to enhance our strategic diplomatic, economic, and military relationship with New Delhi. U.S. Senator Marco Rubio (R-FL)...
Biden’s Cancer Cure Reduction Act
U.S. Senator Marco Rubio (R-FL)
August 15, 2022
Newsweek
…[B]y empowering government bureaucrats to set artificial price caps on drugs, the Inflation Reduction Act will remove the incentive to produce innovative therapeutics for patients in dire need. Even as the legislation lowers routine costs for some, the University of Chicago estimates it will slash national biomedical R&D by $663 billion—almost 20 percent—over the next 17 years.
The impact will be felt heavily by Americans suffering from rare and difficult-to-treat diseases like cancer…. [T]he Democrats’ price controls will cut cancer research by an annual $18 billion. That will undermine…the legislation Senator Michael Bennet (D-CO) and I pushed through Congress in 2017 to expand kids’ access to innovative cancer drugs, as well as the follow-up bill we introduced this year.
It is little comfort that drug price controls won’t take effect until nine or 13 years after initial approval by the U.S. Food and Drug Administration (FDA). Nearly 60 percent of cancer treatments undergo further R&D later on down the line to receive additional indications….
Other areas of research will be affected, too. Just think about the lives and resources saved by mRNA vaccines during the pandemic. Those vaccines required lots of time and money to develop—what similarly significant medicines will we miss out on in the future due to decreased R&D?
We’ve seen this happen before. European countries were the world’s leading medical innovators until price controls set them on a path to mediocrity. If we follow in Europe’s footsteps, we will give China…yet another edge in the contest for global leadership….
There are things we can and should do to reduce drug prices, but dictating those prices from on high is not one of them. Much of what Americans gain through the Inflation Reduction Act will be paid for in lives lost to diseases like cancer, and in geopolitical strength….
Read the rest here.